{"nctId":"NCT00973362","briefTitle":"Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System","startDateStruct":{"date":"2008-03"},"conditions":["Human Papillomavirus Infection"],"count":12896,"armGroups":[{"label":"Adjunct (i.e. Normal Pap)","type":"OTHER","interventionNames":["Device: APTIMA HPV Assay","Device: FDA-Approved HPV DNA Test"]},{"label":"ASC-US","type":"OTHER","interventionNames":["Device: APTIMA HPV Assay","Device: FDA-Approved HPV DNA Test"]}],"interventions":[{"name":"APTIMA HPV Assay","otherNames":[]},{"name":"FDA-Approved HPV DNA Test","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Female 21 years or older (ASC-US study only)\n* Female 30 years or older (Adjunct and ASC-US studies)\n* Subject attending a participating clinic and undergoing a Pap screening exam during the clinic visit\n* Ability to comprehend and sign an IRB-approved Informed Consent Form\n\nExclusion Criteria:\n\n* Diagnosis of cervical disease (cancer or precancerous condition) in the past 12 months\n* Abnormal Pap test result in the past 12 months\n* Subject under 18 years of age and consenting to the study without the presence of their parent or legal guardian\n* Known to be pregnant\n* Having an illness or medical condition that could interfere with or affect the conduct, results, and/or completion of the clinical trial\n* Having an illness or medical condition that the investigator or physician feels would create an unacceptable risk to the subject if she enrolled into the clinical trial\n* Prior vaccination for HPV","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Adjunct Study Arm: Compare Assay Performance for Aptima HPV Assay to a FDA-Approved HPV Assay for Detecting CIN2+","description":"Adjunct 30+ yrs. Population: Aptima HPV Assay Performance for Detecting CIN2+: Compare Clinical Performance of the Aptima HPV Assay to a FDA-Approved HPV Assay for Detecting CIN2+","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"299","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"500","spread":null}]}]}]},{"type":"PRIMARY","title":"Adjunct Study Arm: Compare Assay Performance for FDA-Approved HPV DNA Assay to a FDA-Approved HPV Assay for Detecting CIN2+","description":"Adjunct Study Arm: 30+ yrs. Population: FDA-Approved HPV DNA Assay Performance for Detecting CIN2+: Compare Clinical Performance of the Aptima HPV Assay to a FDA-Approved HPV Assay for Detecting CIN2+","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"401","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"381","spread":null}]}]}]},{"type":"SECONDARY","title":"ASC-US Study Arm: Aptima HPV Assay Performance for Detecting CIN2+ (All Biopsies)","description":"ASC-US Study Arm: 21+ yrs. Population: Aptima HPV assay performance on Tigris System for detecting CIN2+ (All Biopsies)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"315","spread":null},{"groupId":"OG001","value":"343","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"533","spread":null},{"groupId":"OG001","value":"433","spread":null}]}]}]},{"type":"SECONDARY","title":"ASC-US Study Arm: FDA-Approved HPV DNA Assay Performance for Detecting CIN2+ (All Biopsies)","description":"ASC\\_US Study Arm: 21+ yrs. Population for Detecting CIN2+ (All Biopsies): FDA-Approved HPV DNA Assay","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"343","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"433","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":11644},"commonTop":[]}}}